About the organisation
The Asian Fund for Cancer Research Limited (AFCR) is committed to fund cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients. We believe that research holds the key that may end cancer. That’s why at AFCR, we place the highest priority in advancing cutting-edge cancer research in all important fields that will lead to better preventative methods, advanced diagnostic tools, more effective treatment approaches. We fund projects in a variety of important research fields, such as overcoming cancer’s resistance to chemotherapy, developing new screening tests for early detection, optimizing approaches of personalized medicine, and stopping cancer metastasis, etc. AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.
Contact
- Room 2914, Hong Kong Plaza 188 Connaught Road West, Hong Kong, Hong Kong
Focus Areas
Governance & transparency
- No
- No
- No
Annual / Impact Reports
Charity Finder does not have any annual/impact reports for this charity yet. Submit documents.
News feed
Recent items from a feed this charity publishes. Email, social media, and the rest of their website may be more current.
- AFCR Welcomes Mr. Sunil Tuli, Group CEO of King Power Group Hong Kong and President of The Asia Pacific Travel Retail Association, to Its Board of Directors
International business leader and philanthropist brings extensive leadership experience, global connections, and a personal commitment to advancing cancer research. The Asian Fund for Cancer Research Limited (AFCR) is pleased to announce the appointment of Mr. Sunil Tuli, Group CEO of King Power… The post AFCR Welcomes Mr. Sunil Tuli, Group CEO of King Power Group Hong Kong and President of The Asia Pacific Travel Retail Association, to Its Board of Directors appeared first on Asian Fund for Cancer Research Limited.
- Learning from the Galleri Blood Test: Why Earlier Detection Is Only Part of the Answer?
Imagine being able to detect signs of more than 50 types of cancer through a simple blood test, potentially before symptoms appear. That is the promise of Galleri, a multi-cancer early detection (MCED) blood test developed by GRAIL, a US-based biotechnology company,… The post Learning from the Galleri Blood Test: Why Earlier Detection Is Only Part of the Answer? appeared first on Asian Fund for Cancer Research Limited.
- Promising Phase 2 Results for PRV111, a Non-Surgical Oral Cancer Treatment
For patients facing oral cancer, treatment can affect far more than the disease itself. Repeated surgeries may impact the ability to speak, eat, and swallow, making the search for less invasive treatment options especially important. An innovative approach supported by the Asian… The post Promising Phase 2 Results for PRV111, a Non-Surgical Oral Cancer Treatment appeared first on Asian Fund for Cancer Research Limited.
Other
Does not receive recurrent funding from the Social Welfare Department
- 91/7750
- C0994957
- 09/09/2005
Disclaimer
If you represent this organisation, you can claim the listing and update the public profile yourself. Anyone can suggest a correction; we review those before they are applied. Details may still be incomplete or out of date and should be independently verified. We update listings from the IRD's monthly Section 88 list. You should still confirm current tax-exempt status yourself on the IRD search before you rely on it. Read full disclaimer.
Share
Reviews
No written reviews yet.
